0001127602-15-012337.txt : 20150323
0001127602-15-012337.hdr.sgml : 20150323
20150323174532
ACCESSION NUMBER: 0001127602-15-012337
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150319
FILED AS OF DATE: 20150323
DATE AS OF CHANGE: 20150323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36172
FILM NUMBER: 15719993
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-03-19
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242992
CLACKSON TIMOTHY P
C/O ARIAD PHARMACEUTICALS INC
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
President, R&D, CSO
Common Stock
2015-03-19
4
M
0
10833
0
A
439065
D
Common Stock
2015-03-19
4
M
0
20657
7.56
A
460971
D
Common Stock
2015-03-19
4
S
0
20657
9.00
D
440314
D
Common Stock
2015-03-20
4
S
0
5417
8.8443
D
433648
D
Common Stock
2015-03-23
4
M
0
13333
0
A
446981
D
Common Stock
2015-03-23
4
S
0
6667
8.552
D
440314
D
Restricted Stock Units
2015-03-19
4
M
0
10833
0
D
Common Stock
10833
10833
D
Employee Stock Option (Right to Buy)
7.56
2015-03-19
4
M
0
20657
0
D
2006-10-04
2015-10-04
Common Stock
20657
0
D
Restricted Stock Units
2015-03-23
4
M
0
13333
0
D
Common Stock
13333
0
D
Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
Shares were acquired upon the exercise of outstanding stock options at $9.00 per share.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2015-03-23